Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2014

01.07.2014 | Astute Clinician Report

IgG4- Related Disease as a Rare Cause of Tubulointerstitial Nephritis

verfasst von: Lennard Y. W. Lee, Hsiu Yap, Steve Sampson, Brian Ford, Grant Hayman, James Marsh, Amolak S. Bansal

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Isolated IgG4 tubulointerstitial nephritis (TIN) is a rare disorder characterized by raised serum IgG4 levels and histological findings of dense lymphoplasmacytic infiltrates rich in IgG4 positive plasma cells. We report a case of isolated IgG4 TIN that presented with acute kidney injury in an 84 year old man with a polyclonal increase in his total IgG and a raised IgE of 381 kUA/L but without evidence of systemic autoimmunity. We draw a parallel with IgG4-related autoimmune pancreatitis and show raised levels of circulating regulatory T cells. Importantly the plasma levels of the T regulatory cell cytokine, IL10, the TH1 cytokines IL12 and IFNγ, the proinflammatory TNF α and immune regulatory IL27 were all highly raised. Furthermore, the level of IL21 that promotes IgG4 production was also very significantly elevated. These results suggest efforts of the immune system to reduce inflammation and suppress an exaggerated Th2 response. A raised serum IgG in the setting of acute kidney injury and in the absence of autoimmunity and chronic infection should encourage an assessment of the IgG subclasses. Prompt steroid treatment of those with a raised IgG4 may reduce ongoing renal damage.
Literatur
1.
Zurück zum Zitat Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.PubMedCrossRef Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.PubMedCrossRef
2.
3.
Zurück zum Zitat Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343–52.PubMedCentralPubMedCrossRef Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343–52.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Van der Zee JS, Van Swieten P, Aalberse RC. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol. 1986;64(2):415–22.PubMedCentralPubMed Van der Zee JS, Van Swieten P, Aalberse RC. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol. 1986;64(2):415–22.PubMedCentralPubMed
5.
Zurück zum Zitat Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016–23.PubMedCrossRef Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016–23.PubMedCrossRef
7.
Zurück zum Zitat Fukumura Y, Takase M, Mitani K, Suda K, Imamhasan A, Nobukawa B, et al. Amount of CD4+CD25+ regulatory T cells in autoimmune pancreatitis and pilonidal sinus. Pancreas. 2012;41(6):910–5.PubMedCrossRef Fukumura Y, Takase M, Mitani K, Suda K, Imamhasan A, Nobukawa B, et al. Amount of CD4+CD25+ regulatory T cells in autoimmune pancreatitis and pilonidal sinus. Pancreas. 2012;41(6):910–5.PubMedCrossRef
8.
Zurück zum Zitat Kusuda T, Uchida K, Miyoshi H, Koyabu M, Satoi S, Takaoka M, et al. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas. 2011;40(7):1120–30.PubMedCrossRef Kusuda T, Uchida K, Miyoshi H, Koyabu M, Satoi S, Takaoka M, et al. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas. 2011;40(7):1120–30.PubMedCrossRef
9.
Zurück zum Zitat Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol. 2008;38(11):3101–13.PubMedCrossRef Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol. 2008;38(11):3101–13.PubMedCrossRef
10.
Zurück zum Zitat Mizushima I, Yamada K, Fujii H, Inoue D, Umehara H, Yamagishi M, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22(6):859–70.PubMedCentralPubMedCrossRef Mizushima I, Yamada K, Fujii H, Inoue D, Umehara H, Yamagishi M, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22(6):859–70.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Maehara T, Moriyama M, Nakashima H, Miyake K, Hayashida J-N, Tanaka A, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease. Ann Rheum Dis. 2012;71(12):2011–9.PubMedCrossRef Maehara T, Moriyama M, Nakashima H, Miyake K, Hayashida J-N, Tanaka A, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease. Ann Rheum Dis. 2012;71(12):2011–9.PubMedCrossRef
Metadaten
Titel
IgG4- Related Disease as a Rare Cause of Tubulointerstitial Nephritis
verfasst von
Lennard Y. W. Lee
Hsiu Yap
Steve Sampson
Brian Ford
Grant Hayman
James Marsh
Amolak S. Bansal
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2014
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0049-9

Weitere Artikel der Ausgabe 5/2014

Journal of Clinical Immunology 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.